Ascendis Pharma：重归完全独立（纳斯达克：ASND）
· seekingalpha.com
诺和诺德归还TransCon权利后，Ascendis Pharma面临负面情绪，加之先前的合作伙伴退出和失望。在此阅读更多关于ASND股票的内容。
I publish my best ideas and top coverage on the Growth Stock Forum. If you're interested in finding great growth stocks, with a focus on biotech, consider signi...